about
Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza VaccinesReverse Genetics Approaches for the Development of Influenza VaccinesThe Influenza M2 Ectodomain Regulates the Conformational Equilibria of the Transmembrane Proton Channel: Insights from Solid-State Nuclear Magnetic ResonanceProspects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Strategies towards universal pandemic influenza vaccines.Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015An Influenza HA and M2e Based Vaccine Delivered by a Novel Attenuated Salmonella Mutant Protects Mice against Homologous H1N1 Infection.Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis.Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.Subcellular localization and interactions of Infectious Salmon Anemia Virus (ISAV) M1 and NEP as well as host Hsc70.The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin.Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.Generation of New M2e-HA2 Fusion Chimeric Peptide to Development of a Recombinant Fusion Protein Vaccine.Vaccine approaches conferring cross-protection against influenza viruses.Influenza A Virus M2 Protein: Roles from Ingress to Egress.Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells.Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection.Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice
P2860
Q26744622-482D1F8C-9FF5-4BE7-B9F9-E6EC7A4980D1Q28076140-49B0525E-36BC-42D4-8C51-22B8E6437978Q28818506-34D6BE20-5FB6-45F2-ADE0-82D3C88FB276Q30376724-64E3B85F-9F4E-4180-A9B8-FE24187BDE22Q30382226-E56FA20A-4B8B-4D75-B4BF-EBE37B37EFCDQ30398002-4750D632-1A8E-4B32-B536-B17B04850BE7Q33679360-18EFDC31-ACAF-4C28-A3EC-B24D4C7F81CDQ36208249-ED6FF2E7-27A0-4517-910E-1D75D47B097FQ37195802-2606C084-ED13-40FC-AA07-56910715A7EAQ37643000-5A85816A-5520-4635-B8EC-14D524DFBDB7Q38369004-8D3E4446-EC81-4E6B-A07C-F0ECA842AD98Q38719567-44FA10BE-7104-4A4F-A432-B18CE20BAF67Q38822536-24B22D44-23C7-4F6B-817A-13E8AD7EE63EQ40082914-55316743-2272-492B-8EAE-2AA2740B545FQ40157020-0C8F8690-D72C-4305-A381-6F9B1C1E4EDDQ40961165-5744208B-B0AE-4485-9375-E2B832D0C989Q41934895-EAA7838E-F5BF-4410-9BE6-C6EC0AA3178DQ45323658-CA0E0827-0085-4D8B-BA1E-3C95903C526EQ47125471-50EA5BB6-76E2-475A-ABBB-10B57A444989Q47442073-F4C7F46A-0F7D-4A03-9E4C-81DE17CCC43CQ47547060-8D8FED92-C4A4-40B7-AE93-0BD5117BB75AQ47547891-A548C41C-77E3-4510-AEE3-B09B5BB08C10Q47549109-E5C3283D-8B06-471E-8636-5B3F70CC0BC9Q47576940-254E1C75-1E5A-479E-AA57-A1B67B6FFA09Q49465358-C15551E4-FEF1-4E5A-9686-A14843255716Q56221441-7E549414-0DD9-45FC-A988-7F8B609C8CEC
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
M2e-Based Universal Influenza A Vaccines
@ast
M2e-Based Universal Influenza A Vaccines
@en
M2e-Based Universal Influenza A Vaccines
@nl
type
label
M2e-Based Universal Influenza A Vaccines
@ast
M2e-Based Universal Influenza A Vaccines
@en
M2e-Based Universal Influenza A Vaccines
@nl
prefLabel
M2e-Based Universal Influenza A Vaccines
@ast
M2e-Based Universal Influenza A Vaccines
@en
M2e-Based Universal Influenza A Vaccines
@nl
P2093
P2860
P3181
P356
P1433
P1476
M2e-Based Universal Influenza A Vaccines
@en
P2093
Ki Joon Cho
Walter Fiers
Xavier Saelens
P2860
P304
P3181
P356
10.3390/VACCINES3010105
P407
P577
2015-01-01T00:00:00Z